| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.47 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |